Ethiopian Pharmaceuticals Pharmaceutical Import Profile — Ethiopia (DGFT 2022–2026)

Name: Ethiopian Pharmaceuticals Pharmaceutical Import Records from India — 2 Products, $125.4K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Ethiopian Pharmaceuticals — Pharmaceutical Importer Profile (2026) | 2 Products, $125.4K Trade | TransData Nexus

Ethiopian Pharmaceuticals

Pharmaceutical Importer · Ethiopia · Antibiotics Focus · $125.4K Total Trade · DGFT Verified

Ethiopian Pharmaceuticals is a pharmaceutical importer based in Ethiopia with a total trade value of $125.4K across 2 products in 2 therapeutic categories. Based on 4 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Ethiopian Pharmaceuticals sources from 39 verified Indian suppliers, with Fresenius Kabi India Private Limited accounting for 18.5% of imports.

Ethiopian Pharmaceuticals — Import Portfolio & Supplier Network

Ethiopian Pharmaceuticals import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Ethiopian Pharmaceuticals?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Fresenius Kabi India Private Limited	$3.8M	85	18.5%
Macleods Pharmaceuticals Limited	$3.3M	103	16.2%
Leben Laboratories Private Limited	$2.4M

What Formulations Does Ethiopian Pharmaceuticals Import?

Formulation	Value	Ships
Human medicines-sodium chloride	$3.7M	81
Doxyzim 100 (doxycycline capsules BP	$634.6K	13
Compound sodium lactate intravenous	$381.5K	8
Aluminium hydroxide+magnesium	$376.2K	10
Drugs and pharmaceuticals harmless	$321.9K	8
Harmless medicines: artemeter 20MG and	$311.2K	7
Iron folate[ferrous sulfate	$300.0K	6
Paracetamol 500 MG (Each uncoated tablet contains paracetamol BP 500 MG ) ( Pack of 100x10"s)	$245.4K	6
Metronidazole intravenous infusion BP	$200.0K	4
Albendazole 400 MG. tablet 50 x 2 pac	$200.0K	4
M-clox 500 (cloxacillin sodium	$200.0K	4
Harmless medicines: lumerax dt 20/120MG	$200.0K	4
Pharmaceutical product - haeminton -z	$200.0K	4
Chlorhexidine gel 4 w w chlorhexidine gluconate solution USP equ to chlorhexidine 4 w w	$200.0K	4
Peptica gel alumina, magnesia and simethicone oral suspension u.s.p.	$200.0K	4

Ethiopian Pharmaceuticals imports 288 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Tetracycline	Antibiotics	$100.0K	2	0.6%	9
2	Actinomycin	Advanced Oncology	$25.4K	2	0.9%	5

Ethiopian Pharmaceuticals imports 2 pharmaceutical products across 2 categories into Ethiopia totaling $125.4K.

Ethiopian Pharmaceuticals — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Ethiopian Pharmaceuticals is a pharmaceutical importer and buyer based in Ethiopia, specializing in the procurement of finished pharmaceutical formulations from international suppliers, particularly from India. The company plays a pivotal role in ensuring the availability of essential medications within the Ethiopian healthcare system. By sourcing a diverse range of pharmaceutical products, Ethiopian Pharmaceuticals contributes significantly to meeting the country's medical needs.

The company's import activities are characterized by a focus on high-quality, essential medications, including antibiotics and oncology treatments. This strategic sourcing approach underscores Ethiopian Pharmaceuticals' commitment to enhancing the quality of healthcare services in Ethiopia. Through its operations, the company not only supports the local healthcare infrastructure but also fosters international trade relations, particularly with Indian pharmaceutical manufacturers.

2Distribution Network

Ethiopian Pharmaceuticals operates a comprehensive distribution network that spans the entire Ethiopian territory. The company's logistics capabilities are designed to ensure the efficient delivery of pharmaceutical products to various healthcare facilities, including hospitals, clinics, and pharmacies. By maintaining a robust supply chain, Ethiopian Pharmaceuticals ensures that essential medications are accessible to communities across the country.

While specific warehouse locations are not publicly disclosed, the company's distribution system is structured to facilitate timely and reliable deliveries. This strategic distribution framework enables Ethiopian Pharmaceuticals to meet the diverse healthcare needs of the Ethiopian population effectively.

3Industry Role

In Ethiopia's pharmaceutical supply chain, Ethiopian Pharmaceuticals serves as a primary wholesaler and importer. The company is responsible for sourcing and distributing a wide array of pharmaceutical products to various healthcare institutions, ensuring that essential medications are available to meet the country's health demands. By acting as a central link between international suppliers and local healthcare providers, Ethiopian Pharmaceuticals plays a crucial role in maintaining the stability and efficiency of the pharmaceutical supply chain in Ethiopia.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Ethiopian Pharmaceuticals

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Ethiopian Pharmaceuticals demonstrates a high degree of sourcing concentration, with a total import value of $125,000 USD from India across four shipments. The company's portfolio is heavily concentrated, with the top five products accounting for 100% of the total import value. This indicates a strategic focus on specific high-demand pharmaceutical products, such as Tetracycline and Actinomycin, which are critical in the treatment of infections and certain cancers, respectively.

The concentration on a limited number of products suggests a deliberate sourcing strategy aimed at meeting specific therapeutic needs within the Ethiopian market. However, this approach also exposes Ethiopian Pharmaceuticals to potential risks associated with supply chain disruptions or changes in international trade policies affecting these key products. To mitigate such risks, the company may consider diversifying its product portfolio and establishing relationships with multiple suppliers to enhance supply chain resilience.

2Supply Chain Resilience

Ethiopian Pharmaceuticals' supply chain resilience is closely tied to its sourcing strategy. The company's focus on a limited number of products from Indian suppliers necessitates a robust and reliable supply chain to ensure uninterrupted availability of these essential medications. While the concentration on specific products allows for streamlined procurement processes, it also means that any disruptions in the supply chain—such as production delays, shipping issues, or regulatory changes in India—could significantly impact Ethiopian Pharmaceuticals' ability to meet local demand.

Importing Pharmaceuticals into Ethiopia — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Ethiopia

1Regulatory Authority & Framework

The Ethiopian Food and Drug Authority (EFDA) is the primary regulatory body overseeing the importation and distribution of pharmaceutical products in Ethiopia. EFDA is responsible for ensuring the safety, efficacy, and quality of drugs entering the Ethiopian market. Key legislation governing pharmaceutical imports includes Proclamation No. 553/2007, which established the Ethiopian Pharmaceuticals Supply Agency (EPSA), and various regulations set forth by EFDA.

The marketing authorization pathway for Indian generics involves several steps:

1. Certificate of Competence: Importers must obtain a certificate of competence from EFDA, demonstrating their capability to handle pharmaceutical products.

2. Product Registration: Drugs, medical supplies, or instruments must be registered with EFDA before importation.

3. Purchase Order Approval: The purchase order for imported products must be approved by EFDA.

4. Port-Clearance Permit: A port-clearance permit is required to clear imported products from the port of entry.

5. Distribution Authorization: Drugs can only be distributed to authorized institutions and according to their level, as specified by EFDA.

These regulatory measures ensure that imported pharmaceutical products meet the required standards for safety, efficacy, and quality, thereby protecting public health in Ethiopia.

2Import Licensing & GMP

Ethiopian Pharmaceuticals — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Ethiopian Pharmaceuticals' product strategy focuses on importing essential medications, particularly antibiotics and oncology treatments. This focus aligns with the significant healthcare needs in Ethiopia, where infectious diseases and cancer are prevalent. By concentrating on these therapeutic areas, Ethiopian Pharmaceuticals aims to address critical health challenges and improve patient outcomes.

The market demand for these products is driven by the high incidence of infections and cancer cases in Ethiopia. The country's healthcare system requires a steady supply of effective treatments to manage these conditions. Ethiopian Pharmaceuticals' strategic focus on these areas ensures that essential medications are available to meet the needs of the Ethiopian population.

2Sourcing Profile

Ethiopian Pharmaceuticals employs a sourcing strategy that emphasizes the procurement of generic drugs, particularly from Indian manufacturers. This approach allows the company to access high-quality medications at competitive prices, making them more affordable for the Ethiopian market. The company's preference for specific formulations, such as Tetracycline and Actinomycin, reflects a targeted approach to meet the therapeutic needs of the population.

India's well-established pharmaceutical industry, known for its adherence to international quality standards, makes it a preferred sourcing destination for Ethiopian Pharmaceuticals. By importing from India, the company ensures a reliable supply of essential medications that are both effective and cost-effective.

Frequently Asked Questions — Ethiopian Pharmaceuticals

What products does Ethiopian Pharmaceuticals import from India?

Ethiopian Pharmaceuticals imports 2 pharmaceutical products across 2 categories. Top imports: Tetracycline ($100.0K), Actinomycin ($25.4K).

Who supplies pharmaceuticals to Ethiopian Pharmaceuticals from India?

Ethiopian Pharmaceuticals sources from 39 verified Indian suppliers. The primary supplier is Fresenius Kabi India Private Limited (18.5% of imports, $3.8M).

What is Ethiopian Pharmaceuticals's total pharmaceutical import value?

Ethiopian Pharmaceuticals's total pharmaceutical import value from India is $125.4K, based on 4 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Ethiopian Pharmaceuticals focus on?

Ethiopian Pharmaceuticals imports across 2 categories. The largest: Antibiotics (79.7%), Advanced Oncology (20.3%).

Get Full Ethiopian Pharmaceuticals Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Ethiopian Pharmaceuticals

Ethiopian Pharmaceuticals — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Ethiopian Pharmaceuticals?

What Formulations Does Ethiopian Pharmaceuticals Import?

What Products Does Ethiopian Pharmaceuticals Import?

Top Products by Import Value

Ethiopian Pharmaceuticals Therapeutic Categories — 2 Specializations